2/ Boosters would buy us time to develop 2nd generation COVID vaccines specific for Omicron.
But risks remain:
- FALSE SENSE OF SECURITY: your risk of SARS-CoV-2 infection is proportional to levels of transmission in the community, no matter how many boosters you get
➡️
3/
Other risks:
- COMPLACENCY: we need a multi-pronged approach; vaccinations alone will not control SARS-CoV-2, at least not in the short term
Q: Is Omicron more infectious than Delta?
A: We don't know yet. Possibly. Or it could be "hitching a ride" with lax behavior or super spreading.
2/
Q: Does Omicron have a shorter incubation period than Delta?
A: We don't know yet.
Q: Will neutralizing antibodies elicited by the vaccines protect against Omicron?
A: We don't know yet. We may have that data in ~2 weeks.
3/
Q: Is Omicron more virulent than Delta or other variants?
A: We don't know yet. This will likely take months to parse out.
Q: Can we develop mRNA vaccines against Omicron? How long that would take?
A: Yes. Starting now, developed by spring 2022, manufactured by summer 2022.
What about kids who aren't yet vaccinated?
- Kids 5+ years of age: go to vaccines.gov for an appointment
- Rapid test at least every other day over the holidays
2/ There's a lot of confusion about what we mean by PANDEMIC vs EPIDEMIC vs ENDEMIC.
Note that ENDEMIC doesn't mean the virus has gone away.
3/ A good way to think about the difference is the shape of the case curve.
Once almost everyone is immune, then most susceptible people in the population fall into a couple categories:
- newly born
- migrating into the population
- waning immunity (esp elderly)
2/ Even if fully vaccinated & boosted, immunocompromised & other vulnerable people remain at risk for SARS-CoV-2 infection & severe COVID.
We should scale up access to monoclonal antibodies for highly immunocompromised people as PRE-EXPOSURE prophylaxis.
3/ And we should scale up access to COVID antiviral medications for highly immunocompromised people & residents of long-term care facilities and other congregate settings as POST-EXPOSURE prophylaxis.